Literature DB >> 1698198

Corticotropin-releasing hormone- and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease.

H Nawata1, K Higuchi, S Ikuyama, K Kato, H Ibayashi, K Mimura, K Sueishi, H Zingami, H Imura.   

Abstract

A 53-yr-old man with Cushing's disease was found to have a pituitary carcinoma with metastases to the liver and lung which produced both CRH and ACTH simultaneously. Despite removal of the pituitary tumor, his Cushing's disease worsened. Endocrinological examination then demonstrated elevated plasma CRH and markedly elevated plasma ACTH, beta-lipotropin, and cortisol concentrations, increased urinary 17-hydroxycorticosteroid and 17-ketosteroid excretion, and no suppression of serum cortisol after low or high dose dexamethasone administration. Urinary 17-hydroxycorticosteroid excretion increased in response to metyrapone, and lysine vasopressin elicited a striking increase in plasma ACTH. A computed tomographic scan of abdomen revealed multiple hypodense areas in the liver and bilateral adrenal hyperplasia. Postmortem histological examination revealed a necrotic hemorrhagic pituitary carcinoma with metastases to the liver, lung, and olfactory bulb. Immunohistochemical staining, gel filtration, and Northern blot analysis of liver and lung metastases revealed evidence of the production of both CRH and ACTH in these metastases. We concluded that the patient's pituitary carcinoma produced both CRH and ACTH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698198     DOI: 10.1210/jcem-71-4-1068

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Malignant pituitary tumours.

Authors:  G A Kaltsas; A B Grossman
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

Review 2.  Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Authors:  Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

3.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

Review 4.  Ectopic cushing's syndrome due to corticotropin releasing hormone.

Authors:  Manouchehr Nakhjavani; Alireza Amirbaigloo; Soghra Rabizadeh; Fabio Rotondo; Kalman Kovacs; Ali A Ghazi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

5.  Pituitary carcinoma.

Authors:  M D Cusimano; P Ohori; A J Martinez; C Jungreis; D C Wright
Journal:  Skull Base Surg       Date:  1994

Review 6.  Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature.

Authors:  S A Kemink; P Wesseling; G F Pieters; A A Verhofstad; A R Hermus; A G Smals
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 7.  Corticotroph pituitary carcinoma: case report and literature review.

Authors:  D J Holthouse; P D Robbins; R Kahler; N Knuckey; P Pullan
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 8.  Adrenocorticotropin-producing pituitary carcinoma with liver metastasis.

Authors:  B Lormeau; P Miossec; M Sibony; P Valensi; J R Attali
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

9.  An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.

Authors:  Omalkhaire M Alshaikh; Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2019-06       Impact factor: 3.943

10.  Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome.

Authors:  R J Auchus; G Mastorakos; T C Friedman; G P Chrousos
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.